Overview
- U.S. District Judge Denise Cote ruled that Gol’s plan improperly treated creditor silence as consent, voiding the third‑party release provisions.
- The court relied on the U.S. Supreme Court’s 2024 Purdue Pharma precedent, which narrows the use of non‑debtor releases.
- The ruling does not vacate the plan confirmed in May 2025 and sends the case back to the bankruptcy court for adjustments.
- The United States Trustee brought the challenge to the plan’s implicit‑consent mechanism shielding executives and other third parties.
- Gol said it has completed the plan’s restructuring transactions, its operations remain unchanged, and it retains the right to appeal.